| 英文名称 |
中文名称 |
CAS号 |
操作 |
| EP4 receptor antagonist 1 |
|
2287259-07-6 |
详细
|
| Avatrombopag |
阿伐曲泊帕 |
570406-98-3 |
详细
|
| D75-4590 |
化合物 D75-4590 |
384376-42-5 |
详细
|
| Mocravimod hydrochloride |
2-氨基-2-[2-[2-氯-4-[[3-(苄氧基)苯基]硫]苯基]乙基]-1,3-丙二醇盐酸盐 |
509088-69-1 |
详细
|
| Resiquimod-d5 |
Resiquimod D5 |
2252319-44-9 |
详细
|
| SR-31747 |
SR 31747 |
132173-07-0 |
详细
|
| Penehyclidine hydrochloride |
盐酸戊乙奎醚 |
151937-76-7 |
详细
|
| Lysophosphatidylcholines |
L-溶血卵磷脂 |
9008-30-4 |
详细
|
| BIO-1211 |
化合物BIO-1211 |
187735-94-0 |
详细
|
| MSA-2 dimer |
|
2377881-92-8 |
详细
|
| Levocabastine hydrochloride |
1-(4-Cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenylpiperidine-4-carboxylic acid monohydrochloride |
79547-78-7 |
详细
|
| GSK2647544 |
化合物 GSK2647544 |
1380426-95-8 |
详细
|
| XT2 |
化合物 XT2 |
2582816-37-1 |
详细
|
| Sorbicillin |
(2E,4E)-1-(2,4-二羟基-3,5-二甲基苯基)己-2,4-二烯-1-酮 |
79950-85-9 |
详细
|
| GSK2556286 |
化合物GSK2556286 |
1210456-20-4 |
详细
|
| Evatanepag |
2-[3-[N-(4-叔丁基苄基)-N-(吡啶-3-基磺酰基)氨基甲基]苯氧基]乙酸 |
223488-57-1 |
详细
|
| Camobucol |
216167-92-9 |
216167-92-9 |
详细
|
| CZC24832 |
5-(2-氨基-8-氟[1,2,4]三唑并[1,5-A]吡啶-6-基)-N-(叔丁基)-3-吡啶磺酰胺 |
1159824-67-5 |
详细
|
| Timapiprant sodium |
|
950688-14-9 |
详细
|
| Funapide |
|
1259933-16-8 |
详细
|
| Gemilukast |
1232861-58-3 |
1232861-58-3 |
详细
|
| SGK1-IN-1 |
N-[4-(3-amino-2H-pyrazolo[3,4-b]pyrazin-6-yl)phenyl]-5-chloro-2-fluorobenzenesulfonamide |
1279829-87-6 |
详细
|
| TLR7/8-IN-1 |
|
2205095-75-4 |
详细
|
| (S,R,S)-AHPC-C2-amide-benzofuranylmethyl-pyridine |
N1-(苯并呋喃-2-基(吡啶-3-基)甲基)-N4-((S)-1-((2S,4R)-4-羟基-2-(((S)-1-(4-(4-甲基噻唑-5-基)苯基)乙基)氨基甲酰基)吡咯烷-1-基)-3,3-二甲基-1-氧代丁-2-基)丁二酰胺 |
2347517-69-3 |
详细
|
| AP-1/NF-κB activation inhibitor 1 |
AP-1/NF-ΚB活性抑制剂1 |
188936-12-1 |
详细
|
| Integrin modulator 1 |
|
2023788-32-9 |
详细
|
| VAF347 |
2-PYRIMIDINAMINE, 4-(3-CHLOROPHENYL)-N-[4-(TRIFLUOROMETHYL)PHENYL]- |
574759-62-9 |
详细
|
| PHD-1-IN-1 |
化合物PHD-1-IN-1 |
2009343-14-8 |
详细
|
| AGN194204 |
220619-73-8 |
220619-73-8 |
详细
|
| Zaloglanstat |
|
1513852-12-4 |
详细
|
| TAPI-1 |
163847-77-6 |
163847-77-6 |
详细
|
| Pumaprazole |
158364-59-1 |
158364-59-1 |
详细
|
| SMS1-IN-1 |
|
1807943-38-9 |
详细
|
| AXC-715 trihydrochloride |
1-(4-Aminobutyl)-2-butyl-1H-imidazo[4,5-c]quinolin-4-amine Trihydrochloride |
2479276-17-8 |
详细
|
| ALOX15-IN-2 |
化合物 ALOX15-IN-2 |
2764818-23-5 |
详细
|
| WAY-204688 |
796854-35-8 |
796854-35-8 |
详细
|
| GNE-6468 |
化合物 T15404 |
1677668-27-7 |
详细
|
| Lexacalcitol |
来沙骨化醇 |
131875-08-6 |
详细
|
| Eldecalcitol |
艾地骨化醇 |
104121-92-8 |
详细
|
| Carvedilol-d4 |
(±)-Carvedilol-d4 |
1133705-56-2 |
详细
|
| Amodiaquine dihydrochloride |
盐酸阿莫地喹 |
69-44-3 |
详细
|
| Taurocholic acid-d4 (sodium) |
牛磺胆酸钠盐 |
2410279-93-3 |
详细
|
| Aspirin Aluminum |
乙酰水杨酸铝 |
23413-80-1 |
详细
|
| Cloperastine fendizoate |
氯苄哌醚联苯酰苯酸盐 |
85187-37-7 |
详细
|
| Tiron |
邻苯二酚-3,5-二磺酸钠 |
149-45-1 |
详细
|
| Fenoprofen |
3 - (4 -苯氧基苯基)丙酸 |
29679-58-1 |
详细
|
| FK706 |
|
144055-55-0 |
详细
|
| Menbutone |
孟布酮 |
3562-99-0 |
详细
|
| Glafenine hydrochloride |
格拉非宁 盐酸盐 |
65513-72-6 |
详细
|
| Triprolidine hydrochloride monohydrate |
盐酸曲普利啶 |
6138-79-0 |
详细
|
| CXCR2-IN-2 |
|
1838123-21-9 |
详细
|
| CXCR2 antagonist 2 |
化合物 CXCR2 ANTAGONIST 2 |
2647464-91-1 |
详细
|
| ACT-1004-1239 |
|
2178049-58-4 |
详细
|
| ACT-660602 |
化合物 ACT-660602 |
1646267-59-5 |
详细
|
| AZD-5069 |
AZD5069 |
878385-84-3 |
详细
|
| NBI-74330 |
N-[(1R)-1-[3-(4-乙氧基苯基)-3,4-二氢-4-氧代吡啶并[2,3-D]嘧啶-2-基]乙基]-4-氟-N-(3-吡啶基甲基)-3-(三氟甲基)苯乙酰胺 |
855527-92-3 |
详细
|
| (R,R)-CXCR2-IN-2 |
|
1838123-22-0 |
详细
|
| TAK-779 |
TAK 799 ;TAK 779 |
229005-80-5 |
详细
|
| Kynurenic acid sodium |
Kynurenic acid sodium salt |
2439-02-3 |
详细
|
| AMD-070 |
N'-(1H-苯并咪唑-2-甲基)-N'-((S)-5,6,7,8-四氢喹啉-8-基)丁烷-1,4-二胺 |
558447-26-0 |
详细
|
| Reparixin |
REPERTAXIN |
266359-83-5 |
详细
|
| AMD-070 trihydrochloride |
N-(1H-苯并咪唑-2-基甲基)-N-[(8S)-5,6,7,8-四氢-8-喹啉基]-1,4-丁二胺单盐酸盐 |
880549-30-4 |
详细
|
| (2,5-Dioxopyrrolidin-1-yl) 6-[2-[(E,3Z)-3-(3-ethyl-1,3-benzoxazol-2-ylidene)prop-1-enyl]-1,3-benzoxazol-3-ium-3-yl]hexanoate;iodide |
Cy2-NHS活化酯 |
186205-33-4 |
详细
|
| Cyanine 3.5 carboxylic acid |
Cy3.5羧酸 |
1144107-79-8 |
详细
|
| Cy3 amine |
Cy3-伯胺 |
2247688-56-6 |
详细
|
| Cyanine3 maleimide |
Cy3-马来酰亚胺 |
1593644-29-1 |
详细
|
| Cyanine3.5 NHS ester |
Cy3.5-NHS 活化酯 |
2231670-85-0 |
详细
|
| Cyanine5 carboxylic acid |
Cy5 羧酸 |
1032678-07-1 |
详细
|
| Dupilumab |
度匹鲁单抗 |
1190264-60-8 |
详细
|
| CXCR7 modulator 1 |
|
2231812-31-8 |
详细
|
| Tocilizumab |
托珠单抗 |
375823-41-9 |
详细
|
| Cy5-NHS ester |
Cy5-NHS 活化酯 |
1032678-42-4 |
详细
|
| Cyanine 5 amine |
Cy5-伯胺 |
1807529-70-9 |
详细
|
| 3-Acetamidocoumarin |
3-乙酰氨基香豆素 |
779-30-6 |
详细
|
| Cecropin A |
抗菌肽A |
80451-04-3 |
详细
|
| CXCR2 antagonist 8 |
化合物 CXCR2 ANTAGONIST 8 |
182498-30-2 |
详细
|
| Vedolizumab |
维多珠单抗 |
943609-66-3 |
详细
|
| Benralizumab |
|
1044511-01-4 |
详细
|
| Caplacizumab |
卡拉西单抗 |
915810-67-2 |
详细
|
| Deprodone propionate |
丙酸地泼罗酮 |
20424-00-4 |
详细
|
| Tiopinac |
硫平酸 |
61220-69-7 |
详细
|
| IDR-1 |
|
940291-10-1 |
详细
|
| Adalimumab |
阿达木单抗 |
331731-18-1 |
详细
|
| Abatacept |
Unii-7D0yb67S97 |
332348-12-6 |
详细
|
| SMAP-29 |
SMAP 29 |
172485-26-6 |
详细
|
| Sabatolimab |
|
2252262-24-9 |
详细
|
| Vudalimab |
|
2329669-72-7 |
详细
|
| Ipilimumab |
伊匹单抗 |
477202-00-9 |
详细
|
| K6PC-5 |
|
756875-51-1 |
详细
|
| Dimethyl sulfoxide |
二甲基亚砜 |
67-68-5 |
详细
|
| MSX-127 |
NSC-23026 |
6616-56-4 |
详细
|
| SCH 527123 |
3-[[3-[(二甲基氨基)羰基]-2-羟基苯基]氨基]-4-[[(R)-1-(5-甲基呋喃-2-基)丙基]氨基]-3-环丁烯-1,2-二酮 |
473727-83-2 |
详细
|
| SM-276001 |
|
473930-22-2 |
详细
|
| NUCC-390 dihydrochloride |
化合物 NUCC-390 DIHYDROCHLORIDE |
2749281-71-6 |
详细
|
| Parcetasal |
MR 897 |
87549-36-8 |
详细
|
| TGN-020 |
|
51987-99-6 |
详细
|
| PPA-904 |
|
30189-85-6 |
详细
|
| USL311 |
|
1373268-67-7 |
详细
|
| Fresolimumab |
非苏木单抗 |
948564-73-6 |
详细
|
| CXCR7 antagonist-1 |
CXCR7拮抗剂1 |
1613021-99-0 |
详细
|